CheckMyRecalls

Amneal Pharmaceuticals, LLC recalls traMADol Hydrochloride Tablets

Published
8 Apr 2026
Units affected
29,542 bottles
Agency
FDA
Country
United States

The hazard

Failed Impurities/Degradation Specifications: N-nitroso-desmethyl-tramadol impurity (NDSRI) was found out of the specification at 24-month stability interval during Long term stability (25¿C/60%RH).

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

traMADol Hydrochloride Tablets, USP, 50 mg, 500-count bottles, Rx only, Manufactured by: Amneal Pharmaceuticals Pvt. Ltd., Ahmedabad 382220, India, Distributed by: Amneal Pharmaceuticals LLC, Glasgow, KY 42141, NDC 60219-2348-5.

Brand / company
Amneal Pharmaceuticals, LLC
Codes / lots
Lot #: AM230987, Exp. Date 05/2026; AR232387, Exp. Date 12/2026.
Distribution
Nationwide within the USA
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 8 Apr 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.